Sunberg Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
- Paid Up Capital ₹ 9.50 Cr
- Company Age 10 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.02 Cr
- Satisfied Charges ₹ 4.57 Cr
- Revenue Growth 39.36%
- Profit Growth 44.08%
- Ebitda 593.86%
- Net Worth -57.83%
- Total Assets 1.18%
About Sunberg Life Sciences
Sunberg Life Sciences Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 February 2015 and has a history of Ten years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 9.50 Cr.
The company currently has active open charges totaling ₹24.02 Cr. The company has closed loans amounting to ₹4.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sivasamy Manohar, Sulaiman Mohammed, Ogra Kumaran, and Three other members serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397TN2015PTC099067
- Company No.
099067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sunberg Life Sciences?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Balakumar  | Director | 12-Sep-2016 | Current |
| Alagappan Vijayanand | Director | 03-Feb-2015 | Current |
| Sivasamy Manohar | Director | 03-Feb-2015 | Current |
| Sulaiman Mohammed | Director | 04-Oct-2016 | Current |
| Ogra Kumaran | Director | 09-Oct-2019 | Current |
| Nagappan Kannappan | Director | 03-Feb-2015 | Current |
Financial Performance of Sunberg Life Sciences.
Sunberg Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.36% increase. The company also saw a substantial improvement in profitability, with a 44.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 57.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunberg Life Sciences?
In 2023, Sunberg Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tristar Formulations Private LimitedOgra Kumaran is a mutual person
Madras Pharmaceuticals Private LimitedSivasamy Manohar, Sulaiman Mohammed and 1 more are mutual person
Dr Humayun Speciality Hospital Private LimitedSulaiman Mohammed is a mutual person
Softgel Healthcare Private LimitedSulaiman Mohammed and Alagappan Vijayanand are mutual person
Anphar Organics Private Limited.Sivasamy Manohar, Sulaiman Mohammed and 2 more are mutual person
Charges (Loans)
₹24.02 Cr
₹4.57 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 24.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2020 | Hdfc Bank Limited | ₹4.02 Cr | Open |
| 02 Apr 2019 | Hdfc Bank Limited | ₹12.50 Cr | Open |
| 14 Feb 2018 | Hdfc Bank Limited | ₹7.50 Cr | Open |
| 26 Mar 2018 | Dbs Bank Ltd | ₹5.66 M | Satisfied |
| 28 Oct 2016 | Dbs Bank Ltd | ₹4.00 Cr | Satisfied |
How Many Employees Work at Sunberg Life Sciences?
Sunberg Life Sciences has a workforce of 51 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunberg Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunberg Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
